Login
Home
Charts
Search
Watchlist
Products

Beryl Drugs Ltd

BERLDRG·BSE
₹23.98+0.88%Wed, 23 Sept '26 14:56
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Beryl Drugs Ltd

BERLDRG
BSE
₹23.98
+0.88%
|Wed, 23 Sept '26 14:56
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹12Cr
Close
Close Price
₹23.98
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
19.34
PS
Price To Sales
0.55
Revenue
Revenue
₹22Cr
Rev Gr TTM
Revenue Growth TTM
4.55%
PAT Gr TTM
PAT Growth TTM
169.57%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
883665555458
Growth YoY
Revenue Growth YoY%
2.4-6.5-47.3-23.1-30.3-29.562.6-23.2-8.5-28.74.856.7
Expenses
ExpensesCr
773555544447
Operating Profit
Operating ProfitCr
110111111011
OPM
OPM%
8.910.40.915.79.910.99.611.214.2-5.224.58.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000100000-110
Tax
TaxCr
000000000000
PAT
PATCr
000000000010
Growth YoY
PAT Growth YoY%
-20.6121.4-683.3-30.2-96.3-83.9142.9-94.60.0-440.0273.31,000.0
NPM
NPM%
3.34.0-10.95.90.20.92.90.40.2-4.410.22.9
EPS
EPS₹
0.50.6-0.70.70.00.10.30.00.0-0.31.10.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
883665555458
Growth YoY
Revenue Growth YoY%
2.4-6.5-47.3-23.1-30.3-29.562.6-23.2-8.5-28.74.856.7
Expenses
ExpensesCr
773555544447
Operating Profit
Operating ProfitCr
110111111011
OPM
OPM%
8.910.40.915.79.910.99.611.214.2-5.224.58.7
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000100000-110
Tax
TaxCr
000000000000
PAT
PATCr
000000000010
Growth YoY
PAT Growth YoY%
-20.6121.4-683.3-30.2-96.3-83.9142.9-94.60.0-440.0273.31,000.0
NPM
NPM%
3.34.0-10.95.90.20.92.90.40.2-4.410.22.9
EPS
EPS₹
0.50.6-0.70.70.00.10.30.00.0-0.31.10.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
131115131314152727211922
Growth
Revenue Growth%
-1.3-16.638.5-14.4-1.110.03.684.1-0.6-20.9-8.74.5
Expenses
ExpensesCr
131114121213142524201720
Operating Profit
Operating ProfitCr
101111022123
OPM
OPM%
3.9-0.66.97.97.110.32.87.28.55.812.511.5
Other Income
Other IncomeCr
00100100010
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
000011111111
PBT
PBTCr
001100-111111
Tax
TaxCr
000000000000
PAT
PATCr
001100-111101
Growth
PAT Growth%
97.3-368.5322.0-40.5-91.9399.8-375.0216.20.3-24.7-27.4169.6
NPM
NPM%
1.3-4.16.64.60.41.7-4.52.92.92.72.22.8
EPS
EPS₹
0.3-0.82.01.20.10.5-1.31.51.51.10.81.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
131115131314152727211922
Growth
Revenue Growth%
-1.3-16.638.5-14.4-1.110.03.684.1-0.6-20.9-8.74.5
Expenses
ExpensesCr
131114121213142524201720
Operating Profit
Operating ProfitCr
101111022123
OPM
OPM%
3.9-0.66.97.97.110.32.87.28.55.812.511.5
Other Income
Other IncomeCr
00100100010
Interest Expense
Interest ExpenseCr
000000000100
Depreciation
DepreciationCr
000011111111
PBT
PBTCr
001100-111111
Tax
TaxCr
000000000000
PAT
PATCr
001100-111101
Growth
PAT Growth%
97.3-368.5322.0-40.5-91.9399.8-375.0216.20.3-24.7-27.4169.6
NPM
NPM%
1.3-4.16.64.60.41.7-4.52.92.92.72.22.8
EPS
EPS₹
0.3-0.82.01.20.10.5-1.31.51.51.10.81.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
55555555555
Reserves
ReservesCr
21223323445
Current Liabilities
Current LiabilitiesCr
34467886644
Non Current Liabilities
Non Current LiabilitiesCr
00023323321
Total Liabilities
Total LiabilitiesCr
1010111517191818171615
Current Assets
Current AssetsCr
677581011101097
Non Current Assets
Non Current AssetsCr
44499977778
Total Assets
Total AssetsCr
1010111517191818171615
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
55555555555
Reserves
ReservesCr
21223323445
Current Liabilities
Current LiabilitiesCr
34467886644
Non Current Liabilities
Non Current LiabilitiesCr
00023323321
Total Liabilities
Total LiabilitiesCr
1010111517191818171615
Current Assets
Current AssetsCr
677581011101097
Non Current Assets
Non Current AssetsCr
44499977778
Total Assets
Total AssetsCr
1010111517191818171615

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
00030002134
Investing Cash Flow
Investing Cash FlowCr
000-5-201-1-1-1-2
Financing Cash Flow
Financing Cash FlowCr
00022-10-10-2-2
Net Cash Flow
Net Cash FlowCr
0100000001-1
Free Cash Flow
Free Cash FlowCr
0003-2002-110
CFO To PAT
CFO To PAT%
-75.5-83.2-10.1566.7385.5141.371.1323.8106.7569.0868.9
CFO To EBITDA
CFO To EBITDA%
-24.4-573.6-9.6327.320.423.4-114.9127.536.0267.2150.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
00030002134
Investing Cash Flow
Investing Cash FlowCr
000-5-201-1-1-1-2
Financing Cash Flow
Financing Cash FlowCr
00022-10-10-2-2
Net Cash Flow
Net Cash FlowCr
0100000001-1
Free Cash Flow
Free Cash FlowCr
0003-2002-110
CFO To PAT
CFO To PAT%
-75.5-83.2-10.1566.7385.5141.371.1323.8106.7569.0868.9
CFO To EBITDA
CFO To EBITDA%
-24.4-573.6-9.6327.320.423.4-114.9127.536.0267.2150.8

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16764235615111012
Price To Earnings
Price To Earnings
98.06.27.240.614.18.119.419.023.219.3
Price To Sales
Price To Sales
1.20.70.40.30.10.20.40.20.60.50.50.6
Price To Book
Price To Book
2.51.30.90.60.20.40.70.81.71.11.01.2
EV To EBITDA
EV To EBITDA
33.9-129.57.17.06.85.525.35.28.711.34.95.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.623.726.631.332.432.928.530.933.330.4
OPM
OPM%
3.9-0.66.97.97.110.32.87.28.55.812.511.5
NPM
NPM%
1.3-4.16.64.60.41.7-4.52.92.92.72.22.8
ROCE
ROCE%
5.4-2.317.38.93.96.2-4.111.110.510.37.67.6
ROE
ROE%
2.5-7.614.97.80.63.0-9.09.58.66.14.34.3
ROA
ROA%
1.6-4.39.24.00.31.3-3.74.44.43.62.82.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16764235615111012
Price To Earnings
Price To Earnings
98.06.27.240.614.18.119.419.023.219.3
Price To Sales
Price To Sales
1.20.70.40.30.10.20.40.20.60.50.50.6
Price To Book
Price To Book
2.51.30.90.60.20.40.70.81.71.11.01.2
EV To EBITDA
EV To EBITDA
33.9-129.57.17.06.85.525.35.28.711.34.95.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.623.726.631.332.432.928.530.933.330.4
OPM
OPM%
3.9-0.66.97.97.110.32.87.28.55.812.511.5
NPM
NPM%
1.3-4.16.64.60.41.7-4.52.92.92.72.22.8
ROCE
ROCE%
5.4-2.317.38.93.96.2-4.111.110.510.37.67.6
ROE
ROE%
2.5-7.614.97.80.63.0-9.09.58.66.14.34.3
ROA
ROA%
1.6-4.39.24.00.31.3-3.74.44.43.62.82.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Beryl Drugs Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/otujp8nv1br3nsrpj21us5vx.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/q17gca4phfd4nj990bc4g4c0.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/m30ef2srcir1m01kac2vgh5p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/00n0gw3f8zzd8d993xz6fqi8.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/wh64ghdccy8zc9yyevn4guwi.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/s39yed97scfsyw9slixt6p9s.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/g5lrbiyidobyikuy2vz82nyn.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/vek20odjg463igxjxvk7djk3.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/yfe51r2cvfcb54hijr0ckngo.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/1r7mnp8faxf9x5yqffsnks1f.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/t0gdrpjz3dcqvr9h1aqf0o7p.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/p9qob8z0kfux5gj925bh0uit.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ddfa1tx3mecbzc1tnbuo823f.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/tz542rxukgnubft22n2aml1p.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/c68p00mhps0s98rc7dy839o7.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies